AT&S Employs Innovative PCB Technology to Hearing Aids and Pacemakers to Prostheses

Reading time ( words)

The trend for miniaturization and digitalization is shaping medical technology, too. Systems and components for treatment, diagnosis and patient monitoring are becoming ever smaller and more powerful. In medical technology, more than any other field, safety and reliability – despite progressive miniaturization – are an absolute priority, since reliable functioning can be vitally important.

With its innovative and sophisticated interconnection technologies, AT&S is enabling a wide variety of applications – some of them entirely new – both on and inside the human body. The company is one of the few printed circuit board (PCB) manufacturers that is certified to EN ISO 13485, the standard for medical devices. Thanks to the performance and quality of its products, paired with extensive technical and consulting expertise in the medical sector, AT&S is contributing to making even smaller and more powerful products for medical treatment, monitoring vital functions (blood sugar, blood pressure, ECG) and diagnosis/imaging (MRT, X-ray, ultrasound). Extremely compact pacemakers with long battery life, hearing aids with intelligent adjustment, local neurostimulators for pain therapy, and cochlear implants allow improved and new treatment methods to benefit patients.

The key challenges in medical technology are advancing miniaturization, maximum quality, and developing new biocompatible materials. With its sophisticated, reliable technologies, AT&S has for many years been a world-leading PCB supplier for hearing aids, for example. State-of-the-art cochlear implants also use AT&S technology. A cochlear implant is an electronic medical device that performs the function of damaged parts of the inner ear (cochlea) to transmit sounds to the brain.

Miniaturized PCBs are also facilitating completely new treatment approaches. For example, the functionality of a human hand – representing a highly complex system – has been largely replicated in a prosthesis using the latest interconnection technology from AT&S. “Smart capsules” are now a reality too. Using highly miniaturized PCB technology as a substrate for the electronics, they are able to monitor specific body parameters and transmit the relevant data or deliver a controlled dose of medication. Finally, extremely compact interconnection technologies are also being used in wearables and tracking systems for lifestyle applications.

“Medical technology is facing great challenges with regard to demographic changes and the modern lifestyle,” says Walter Moser, Chief Sales Officer (CSO) of the Business Unit Automotive, Industrial and Medical at AT&S. “With our advanced, constantly developing interconnection technologies and our consulting expertise, we are ideally positioned to help our customers find solutions to these current problems. That includes new cost-efficient, patient-friendly treatments and diagnostic procedures, as well as user-optimized monitoring solutions.”

AT&S will present its innovative PCB technologies for medical technology at COMPAMED (13-16 November 2017) in Düsseldorf (hall 8b, stand F04).

05/10/2023 | Pete Starkey, I-Connect007

It’s been a little while since I first had the opportunity to review an EIPC Technical Snapshot webinar. This excellent series began in October 2020 when our industry was besieged by the COVID-19 pandemic. It has continued successfully as restrictions have lifted and provides an effective channel for the efficient sharing of relevant knowledge that complements the traditional live conferences. The 20th in the series, in December 2022, focused on environmental issues impacting the electronics industry. In early February, EIPC held its live Winter Conference in Lyon and now, by popular demand, the 21st Technical Snapshot fills a slot before the Summer Conference scheduled for mid-June in Munich.

04/27/2023 | Chris Wall, technical director, Electra Polymers

Ever since liquid photoimageable solder masks (LPISMs) were introduced, their UV exposure speed has been a key factor in their performance. The LPISM is coated onto the PCB, dried, and then selectively exposed with UV light via a phototool, or more recently, via direct imaging using LED or lasers. The exposed areas polymerise and become insoluble in the developing solution. The polymerisation is initiated by one or more chemicals called photoinitiators, which are components of the LPISM.

02/27/2023 | Pete Starkey, I-Connect007

The EIPC Winter Conference returned to the Metropolis of Lyon in eastern France this month. In 2018, the venue was Villeurbanne in the Auvergne-Rhône-Alpes region. Five years later the setting was the Groupama Stadium in Décines-Charpieu, and leaders of the European printed circuit community gathered in expectation of a spectacular programme of 16 presentations, a visit to a nuclear power station, and an invaluable networking opportunity. They weren’t disappointed.